JCS/T2D JCS/T2D
JCS/T2D JCS/T2D
  • Home
  • About
  • Disclaimer
  • Privacy
  • Search
  • Contact Us
  • A Clearer, More Human View of Glucose Patterns

  • Abbott and Dexcom Settle Global Patent Disputes Over CGM Technologies

  • Dexcom G7 15-Day CGM Wins FDA Clearance

  • Dexcom Stelo: First Over-the-Counter Glucose Biosensor Now Available in the U.S.

  • Dexcom Submits 15-Day G7 CGM to FDA for Approval

  • Eli Lilly's Once-Weekly Insulin Efsitora Alfa Shows Positive Phase 3 Results

  • Mounjaro Shortage: A Challenge for Diabetes and Obesity Patients

  • Ozempic Linked to Reduced Tobacco-Related Healthcare Needs

  • Regulatory Hurdles for Awiqli: Approval in Canada and EU, Concerns in the US

  • Subtle Yet Significant Changes: The 2024 ADA Standards of Care in Diabetes

  • Viewing Type 2 Diabetes as a Vascular Disease

  • You are here:  
  • Home
  • Tags
  • Diabetes Management
 

JCS/T2D

We are advocates. We learn. We share. We inform.
Bringing clarity to type 2 diabetes, obesity care, health research, and the data behind them.

Content is provided for educational and informational purposes and is not medical advice.

Helpful Links

About Us
Contact Us
JCS Analytics

Copyright © 2026 JCS/T2D - A Diabetes Journey. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.